PROGRAMME
Immune tolerance induction in haemophilia
Chairs: Giovanni Di Minno (Italy), Sebastien Lacroix-Desmazes (France)
09:00
CAR-T cell derived strategies for the induction of tolerance towards therapeutic factor VIIIChristoph Königs (Germany)
09:20
Maternal delivery of factor VIII to induce factor VIII toleranceSebastien Lacroix-Desmazes (France)
09:40
Discussion
Thrombotic microangiopathies (TMAs) and atypical haemolytic uremic syndrome (aHUS)
Chairs: Giuseppe Remuzzi (Italy), Nicola Ciavarella (Italy)
09:50
Novel aspects of pathophysiology, diagnosis, and treatment of transplant-associated TMAEleni Gavriilaki (Greece)
10:10
Old and new mechanisms for atypical HUSMassimo Cugno (Italy)
10:30
Discussion
10:40
Coffee break
Remaining challenges in haemophilia
Chairs: Silvio Garattini (Italy), Pier Mannuccio Mannucci (Italy)
11:10
Immunogenicity of factor VIII products stemming from EUropean HAemophilia Safety Surveillance (EUHASS)Kathelijn Fischer (The Netherlands)
11:30
Haemophilia and thrombosis – the gap is narrowingMike Makris (UK)
11:50
Discussion
Satellite Symposium
12:00
Novo Nordisk
PROGRAMME
13:00
Lunch
Satellite Symposium
14:00
Sobi and Sanofi Genzyme
PROGRAMME
Von Willebrand disease & von Willebrand factor
Chairs: Giancarlo Castaman (Italy), Augusto B. Federici (Italy)
15:00
Von Willebrand factor clearance: mechanisms and clinical impactDavid Lillicrap (Canada)
15:20
Weibel-Palade bodies and regulation of von Willebrand factor sizeDaniel Cutler (UK)
15:40
Discussion
15:50
Coffee break
16:20
Future therapies in von Willebrand disease: allele selective silencing of von Willebrand factorJeroen Eikenboom (The Netherlands)
16:40
Future therapies in von Willebrand disease: time for a tailored fit?Caterina Casari (France)
17:00
Discussion
17.15
E-POSTER SESSION
PROGRAMME